Repeated implantation failure and add-ons: what the evidence says
On this page you will learn
- How ESHRE describes recurrent implantation failure (RIF), and why age and embryo choice matter
- A step-by-step work-up, separating useful tests from fashionable ones
- What the 2023 ESHRE add-ons recommendations say about popular extras
- How to talk about add-ons honestly with a couple
What RIF means
After two or three failed transfers, couples ask "what is wrong?" Often nothing is wrong beyond chance. The 2023 ESHRE good practice paper describes RIF as a pattern seen only in IVF: embryos thought to be viable are transferred, yet a positive pregnancy test fails to follow often enough to justify a closer look. The number of failures that counts depends on the woman's age, the stage of the embryos and whether they were tested, so ESHRE uses a cumulative-chance threshold, not a fixed count.
Source: 2023, ESHRE Working Group on Recurrent Implantation Failure (Cimadomo et al.), Human Reproduction Open hoad023 - ESHRE good practice recommendations on recurrent implantation failure
Embryo chromosome errors, which rise with the woman's age, are the commonest reason a good-looking embryo does not implant. Keep that at the front of every RIF conversation.
Source: 2023, ESHRE Working Group on Recurrent Implantation Failure (Cimadomo et al.), Human Reproduction Open hoad023 - ESHRE good practice recommendations on recurrent implantation failure
A work-up in steps
Step 1: review the story. Recheck age, ovarian response, the embryo reports (page 53), the transfer notes and any difficult transfers (page 56). ESHRE recommends re-assessing lifestyle factors such as smoking and weight, and re-checking endometrial thickness.
Source: 2023, ESHRE Working Group on Recurrent Implantation Failure (Cimadomo et al.), Human Reproduction Open hoad023 - ESHRE good practice recommendations on recurrent implantation failure
Step 2: targeted tests. ESHRE lists tests that can be considered: karyotype of both partners, hysteroscopy (especially when the scan hints at a cavity problem), a 3D scan if not done before, assessment for chronic endometritis, thyroid function and progesterone levels. Antiphospholipid testing is recommended when the woman has other thrombosis risk factors.
Source: 2023, ESHRE Working Group on Recurrent Implantation Failure (Cimadomo et al.), Human Reproduction Open hoad023 - ESHRE good practice recommendations on recurrent implantation failure
Step 3: leave out the noise. ESHRE does not recommend uterine microbiome profiling, natural killer cell tests, blood cytokines, HLA-C matching or sperm DNA fragmentation in RIF work-up. It also finds too little evidence for the routine use of any commercial endometrial receptivity test.
Source: 2023, ESHRE Working Group on Recurrent Implantation Failure (Cimadomo et al.), Human Reproduction Open hoad023 - ESHRE good practice recommendations on recurrent implantation failure
Treatments: what helps and what does not
Treat what you find. If chronic endometritis is shown, antibiotics can be considered; thyroid disease follows the usual thyroid guidelines. Blastocyst-stage transfer and embryo testing for aneuploidy (PGT-A, page 66) can be considered.
ESHRE recommends against a long list of treatments sold for RIF: endometrial scratching, intralipid infusion, immunoglobulin infusion, heparin to raise the live birth chance, and intrauterine platelet-rich plasma, hCG or G-CSF. Assisted hatching is also not recommended.
Source: 2023, ESHRE Working Group on Recurrent Implantation Failure (Cimadomo et al.), Human Reproduction Open hoad023 - ESHRE good practice recommendations on recurrent implantation failure
Add-ons: the 2023 ESHRE view
ESHRE defines add-ons as optional extras offered on top of standard IVF, usually at extra cost to the patient. Its working group made 42 recommendations; none could rest on high-quality evidence, and most extras were judged not ready for routine use.
Source: 2023, ESHRE Add-ons Working Group, Human Reproduction 38(11):2062-2104 - Good practice recommendations on add-ons in reproductive medicine
- Not recommended: endometrial receptivity tests, immune blood tests and immune treatments, assisted hatching, glucocorticoids, antioxidants, intrauterine G-CSF, PRP or hCG, and hormonal adjuncts during stimulation
- Not for routine use: endometrial scratching, elective freeze-all for everyone, PGT-A, sperm DNA damage tests
- Not to improve live birth: time-lapse imaging
- Recommended: hyaluronic acid added to the transfer medium, used with a single embryo transfer policy while the multiple pregnancy risk is watched
- Can be considered in RIF only: screening hysteroscopy (not for routine use otherwise)
- Not for non-male factor: ICSI
Source: 2023, ESHRE Add-ons Working Group, Human Reproduction 38(11):2062-2104 - Good practice recommendations on add-ons in reproductive medicine
Talking about add-ons honestly
Couples arrive with lists from the internet or from friends. Take each item seriously, then answer three questions with them: what is the evidence of benefit, what is the harm or cost, and what will we do differently if the test is abnormal? A test that would not change the plan should not be done. Record the discussion in the file.
The ART Act also requires counselling on chances, risks and cost before treatment. Selling an unproven extra as if it raised the chance does not meet that duty.
Source: 18 Dec 2021, Government of India (Act No. 42 of 2021) - The Assisted Reproductive Technology (Regulation) Act, 2021 (section 21(c))
At the clinic
On Day OB-6 the faculty runs a case clinic on one anonymised repeated-failure file. You list the tests you would order, the ones you would leave out, and the evidence for each. Ultrasound scans are watched only: no trainee holds the probe on a patient (PCPNDT Act).
The lab side
Ask the embryologist to summarise the embryo history across all cycles: fertilisation, development and what was transferred or frozen. Lab detail stays basic for you; the summary is what you need for the RIF discussion.
Common mistakes
- Calling two failed transfers of untested embryos in an older woman "RIF" without looking at age
- Ordering a panel of immune tests
- Offering a treatment because the couple asked for it
- Not writing down the evidence discussion
Key points
- RIF depends on age, embryo stage and testing, not a fixed count
- Review the story first; then a short list of targeted tests
- Most immune and endometrial extras are not recommended
- Discuss evidence, harm, cost and whether a result would change the plan
Check yourself
Answer in your head first, then tap a question to see a short answer. Full model answers are in the faculty guidebook.
1. How does ESHRE describe recurrent implantation failure (RIF)?
Repeated transfer of embryos thought viable that fails to give a positive pregnancy test often enough to justify investigation.
2. Name three investigations ESHRE recommends or suggests in suspected RIF.
Review of lifestyle, re-check of endometrial thickness, and antiphospholipid testing when other risk factors exist; hysteroscopy or 3D scan can be considered.
3. List four interventions ESHRE does not recommend in RIF.
Endometrial scratching, intralipid, IVIG and heparin to raise live birth; also intrauterine PRP, hCG or G-CSF.
4. What is an add-on, as ESHRE uses the word?
An optional extra test or treatment on top of standard IVF, usually at extra cost to the patient.
5. Give two add-ons ESHRE does recommend or accept, and two it does not.
Recommended: hyaluronic acid in the transfer medium (with single embryo transfer and a watch on multiples); screening hysteroscopy can be considered in RIF. Not recommended: endometrial receptivity tests, assisted hatching, immune treatments, PGT-A routinely.
6. From page 59: what should a review visit after a failed cycle cover?
What happened in the cycle, what can change, the couple's feelings and the next step, written in the file.
Training note. Training content for registered medical practitioners. Trainees observe all patient care; they do not treat patients during the programme.
Questions on this page
Does endometrial scratching help after failed IVF?
ESHRE does not recommend it for routine use or in recurrent implantation failure.
Are immune tests useful after failed transfers?
ESHRE does not recommend immune blood tests or immune treatments.
The Genesis Doctors' Textbook is teaching text for registered medical practitioners on the doctor programmes of the Genesis ART Training Academy. It is not treatment advice and gives no medicine doses; trainees observe all patient care, ultrasound scans are watched only (PCPNDT Act), and bench skills are practised under supervision. Page numbers never change.
